{:metadata {:description [{"text" "<p>The beta-site APP cleaving enzyme-1 (BACE1), also known as Aspartyl protease 2 and memapsin-2, mediates one of the two proteolytic cleavages of beta-amyloid precursor protein (APP) to yield the amyloid Î²-peptide (Abeta), a key pathogenic agent in Alzheimer's disease (AD) [[cite:PUB00074551]]. Axonal and Schwann cell BACE1 is also required for remyelination of injured nerves [[cite:PUB00074553]]. BACE1 inhibitor drugs have been evaluated for AD treatment [[cite:PUB00074554]]. BACE1 is ([ec:3.4.23.46]) and MEROPS identifier A01.004.</p>", "llm" false, "checked" false, "updated" false}], :is-reviewed-llm false, :representative-structure nil, :overlaps-with [{"accession" "IPR021109", "name" "Aspartic peptidase domain superfamily", "type" "homologous_superfamily"}], :member-databases {"prints" {"PR01816" "Beta-site APP cleaving enzyme 1 (BACE1)"}}, :is-updated-llm false, :name {"name" "Beta-secretase BACE1", "short" "BACE1"}, :wikipedia nil, :source-database "interpro", :type "family", :counters {"structures" 428, "domain_architectures" 0, "proteomes" 605, "taxa" 2252, "subfamilies" 0, "interactions" 0, "matches" 8617, "sets" 0, "proteins" 1424, "structural_models" {"alphafold" 930}, "pathways" 1}, :integrated nil, :cross-references {"ec" {"displayName" "ENZYME", "description" "ENZYME is a repository of information relative to the nomenclature of enzymes. It is primarily based on the recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB) and it describes each type of characterized enzyme for which an EC (Enzyme Commission) number has been provided.", "rank" 19, "accessions" [{"accession" "3.4.23.-", "url" "https://enzyme.expasy.org/EC/3.4.23.-"} {"accession" "3.4.23.46", "url" "https://enzyme.expasy.org/EC/3.4.23.46"}]}}, :set-info nil, :accession "IPR009120", :literature {"PUB00074554" {"URL" nil, "issue" "9", "authors" ["Vassar R."], "ISO_journal" "Alzheimers Res Ther", "DOI_URL" "http://dx.doi.org/10.1186/s13195-014-0089-7", "medline_journal" "Alzheimers Res Ther", "title" "BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.", "year" 2014, "raw_pages" "89", "volume" "6", "ISBN" nil, "PMID" 25621019}, "PUB00074551" {"URL" nil, "issue" "8", "authors" ["Okada H" "Zhang W" "Peterhoff C" "Hwang JC" "Nixon RA" "Ryu SH" "Kim TW."], "ISO_journal" "FASEB J.", "DOI_URL" "http://dx.doi.org/10.1096/fj.09-146357", "medline_journal" "FASEB J", "title" "Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing.", "year" 2010, "raw_pages" "2783-94", "volume" "24", "ISBN" nil, "PMID" 20354142}, "PUB00074553" {"URL" nil, "issue" "9", "authors" ["Hu X" "Hu J" "Dai L" "Trapp B" "Yan R."], "ISO_journal" "J. Neurosci.", "DOI_URL" "http://dx.doi.org/10.1523/JNEUROSCI.5207-14.2015", "medline_journal" "J Neurosci", "title" "Axonal and Schwann Cell BACE1 Is Equally Required for Remyelination of Peripheral Nerves.", "year" 2015, "raw_pages" "3806-14", "volume" "35", "ISBN" nil, "PMID" 25740511}}, :go-terms [{"identifier" "GO:0004190", "name" "aspartic-type endopeptidase activity", "category" {"code" "F", "name" "molecular_function"}} {"identifier" "GO:0006508", "name" "proteolysis", "category" {"code" "P", "name" "biological_process"}} {"identifier" "GO:0016020", "name" "membrane", "category" {"code" "C", "name" "cellular_component"}}], :entry-id nil, :hierarchy {"accession" "IPR001461", "name" "Aspartic peptidase A1", "type" "Family", "children" [{"accession" "IPR009119", "name" "Beta-secretase BACE", "type" "Family", "children" [{"accession" "IPR009120", "name" "Beta-secretase BACE1", "type" "Family", "children" []} {"accession" "IPR009121", "name" "Beta-secretase BACE2", "type" "Family", "children" []}]} {"accession" "IPR033144", "name" "Cathepsin D", "type" "Family", "children" []}]}, :is-llm false, :entry-annotations {}}}